Segui
Giuseppe Ermondi
Titolo
Citata da
Citata da
Anno
NMR study of solution structures and dynamics of lanthanide (III) complexes of DOTA
S Aime, M Botta, G Ermondi
Inorganic Chemistry 31 (21), 4291-4299, 1992
4091992
Novel contrast agents for magnetic resonance imaging. Synthesis and characterization of the ligand BOPTA and its Ln (III) complexes (Ln= Gd, La, Lu). X-ray structure of …
F Uggeri, S Aime, PL Anelli, M Botta, M Brocchetta, C de Haeen, ...
Inorganic Chemistry 34 (3), 633-643, 1995
2401995
Impact of dynamically exposed polarity on permeability and solubility of chameleonic drugs beyond the rule of 5
M Rossi Sebastiano, BC Doak, M Backlund, V Poongavanam, B Over, ...
Journal of medicinal chemistry 61 (9), 4189-4202, 2018
1762018
Furoxans as nitric oxide donors. 4-Phenyl-3-furoxancarbonitrile: thiol-mediated nitric oxide release and biological evaluation
C Medana, G Ermondi, R Fruttero, A Di Stilo, C Ferretti, A Gasco
Journal of medicinal chemistry 37 (25), 4412-4416, 1994
1621994
New 1, 4-dihydropyridines conjugated to furoxanyl moieties, endowed with both nitric oxide-like and calcium channel antagonist vasodilator activities
A Di Stilo, S Visentin, C Cena, AM Gasco, G Ermondi, A Gasco
Journal of medicinal chemistry 41 (27), 5393-5401, 1998
1461998
Intramolecular hydrogen bonding: An opportunity for improved design in medicinal chemistry
G Caron, J Kihlberg, G Ermondi
Medicinal Research Reviews 39 (5), 1707-1729, 2019
1032019
Relaxometric, Structural, and Dynamic NMR Studies of DOTA-like Ln(III) Complexes (Ln = La, Gd, Ho, Yb) Containing a p-Nitrophenyl Substituent
S Aime, M Botta, G Ermondi, E Terreno, PL Anelli, F Fedeli, F Uggeri
Inorganic Chemistry 35 (10), 2726-2736, 1996
951996
Conformational sampling of macrocyclic drugs in different environments: can we find the relevant conformations?
V Poongavanam, E Danelius, S Peintner, L Alcaraz, G Caron, ...
ACS omega 3 (9), 11742-11757, 2018
842018
Synthesis and NMRD studies of gadolinium (3+) complexes of macrocyclic polyamino polycarboxylic ligands bearing. beta.-benzyloxy-. alpha.-propionic residues
S Aime, M Botta, G Ermondi, F Fedeli, F Uggeri
Inorganic Chemistry 31 (6), 1100-1103, 1992
781992
Molecular and statistical modeling of reduction peak potential and lipophilicity of platinum (IV) complexes
JA Platts, G Ermondi, G Caron, M Ravera, E Gabano, L Gaviglio, G Pelosi, ...
JBIC Journal of Biological Inorganic Chemistry 16, 361-372, 2011
742011
Mechanisms of liposomes/water partitioning of (p-methylbenzyl) alkylamines
R Fruttero, G Caron, E Fornatto, D Boschi, G Ermondi, A Gasco, ...
Pharmaceutical research 15, 1407-1413, 1998
641998
Contribution of ionization and lipophilicity to drug binding to albumin: a preliminary step toward biodistribution prediction
G Ermondi, M Lorenti, G Caron
Journal of medicinal chemistry 47 (16), 3949-3961, 2004
612004
Molecular descriptors for polarity: the need for going beyond polar surface area
G Caron, G Ermondi
Future Medicinal Chemistry 8 (17), 2013-2016, 2016
572016
Determination of metal–proton distances and electronic relaxation times in lanthanide complexes by nuclear magnetic resonance spectroscopy
S Aime, L Barbero, M Botta, G Ermondi
Journal of the Chemical Society, Dalton Transactions, 225-228, 1992
571992
Flexibility in early drug discovery: focus on the beyond-Rule-of-5 chemical space
G Caron, V Digiesi, S Solaro, G Ermondi
Drug Discovery Today 25 (4), 621-627, 2020
552020
Calculating Virtual log P in the Alkane/Water System (log PNalk) and Its Derived Parameters Δlog PNoct-alk and log DpHalk
G Caron, G Ermondi
Journal of medicinal chemistry 48 (9), 3269-3279, 2005
542005
Development of molecular hydrogen-bonding potentials (MHBPs) and their application to structure–permeation relations
S Rey, G Caron, G Ermondi, P Gaillard, A Pagliara, PA Carrupt, B Testa
Journal of Molecular Graphics and Modelling 19 (6), 521-535, 2001
512001
Lipophilicity behaviour of the zwitterionic antihistamine cetirizine in phosphatidylcholine liposomes/water systems
GP van Balen, G Caron, G Ermondi, A Pagliara, T Grandi, G Bouchard, ...
Pharmaceutical research 18, 694-701, 2001
502001
Steering new drug discovery campaigns: permeability, solubility, and physicochemical properties in the bRo5 chemical space
G Caron, J Kihlberg, G Goetz, E Ratkova, V Poongavanam, G Ermondi
ACS Medicinal Chemistry Letters 12 (1), 13-23, 2021
472021
Ionic partition diagram of the zwitterionic antihistamine cetirizine
G Bouchard, A Pagliara, GP van Balen, PA Carrupt, B Testa, V Gobry, ...
Helvetica Chimica Acta 84 (2), 375-387, 2001
472001
Il sistema al momento non può eseguire l'operazione. Riprova più tardi.
Articoli 1–20